Viridian Therapeutics, Inc.\DE (VRDN) Return on Sales Growth (3y) (2016 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) Return on Sales Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 0.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 0.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Viridian Therapeutics, Inc.\DE | 631.55 Mn | 631.55 Mn | - | -97.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -97.00 |
| Dec 31, 2025 | -316.00 |
| Sep 30, 2025 | 24.00 |
| Jun 30, 2025 | -1,374.00 |
| Mar 31, 2025 | -1,189.00 |
| Dec 31, 2024 | -962.00 |
| Sep 30, 2024 | -996.00 |
| Jun 30, 2024 | -997.00 |
| Mar 31, 2024 | -788.00 |
| Dec 31, 2023 | 511.00 |
| Sep 30, 2023 | -650.00 |
| Jun 30, 2023 | -723.00 |
| Mar 31, 2023 | -685.00 |
| Dec 31, 2022 | -429.00 |
| Sep 30, 2022 | -15.00 |
| Jun 30, 2022 | -113.00 |
| Mar 31, 2022 | -87.00 |
| Dec 31, 2021 | -114.00 |
| Sep 30, 2021 | -58.00 |
| Jun 30, 2021 | -12.00 |